GENE ONLINE|News &
PRNEWSWIRE
Innovent's Sintilimab plus Chemotherapy Demonstrated PFS Benefit in Patients with EGFR-mutated Non-Squamous Non-Small Cell Lung Cancer in the Second Interim Analysis Results of the ORIENT-31 Study
2022-09-07
Non-invasive skin immune biomarker test helps predict development of eczema in babies, new study presented at the EADV Congress finds
2022-09-06
Dizal Announces Sunvozertinib Meets Primary Endpoint in its First Pivotal Study in Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations at 2022 ESMO
2022-09-05
Pxierra is launching world’s first non-contact heart rate & breathe rate measurement AI baby monitor
2022-09-01
Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator
2022-08-31
GC Biopharma and Speragen Sponsored an Externally Led – Patient Focused Drug Development with FDA Attendance
2022-08-30
Minderoo Foundation and Illumina Commit $40M to Apply Advanced Genomics to Marine Conservation
2022-08-29
Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma
2022-08-29
PFIZER RANKED LEADING COMPANY IN ASIA FOR COVID-19 RESPONSE AND PATIENT-CENTRIC APPROACH BY ASIAN PATIENT GROUPS
2022-08-25
GenScript ProBio Congratulates Selecxine on FDA Clearance of IND Application for Innovative Antibody Drug Program
2022-08-23
DxGen Corp. and Precision Diabetes, Inc. Announce Strategic Partnership to Launch New Diabetes Point-Of-Care Testing Analyzer into the U.S. Market.
2022-08-22
LATEST
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
